TrusteSolutions Announces 2023 Growth in Chapter 7 Case Management Market and 100% Satisfaction Ratings for Software and Support
HOUSTON, Jan. 30, 2024 /PRNewswire/ — TrusteSolutions (TES), the technology innovator of the most advanced case management platform in the enterprise-level, cloud-based case management software industry for the bankruptcy and receivership market, shared its steady growth numbers in 2023 with f
Superior HealthPlan Celebrates 25 Years of Putting Members First
With more than 2 million members, Superior has grown into the largest Medicaid managed care organization in Texas. AUSTIN, Texas, Jan. 30, 2024 /PRNewswire/ — Superior HealthPlan (“Superior”), the leading managed care organization in the state of Texas and a wholly owned subsidi
Shutterstock Increases Quarterly Dividend By 11% to $0.30
New York, Jan. 30, 2024 /PRNewswire/ — Shutterstock, Inc. (NYSE: SSTK), a leading global creative platform connecting brands and businesses to high-quality content, today announced that its Board of Directors has declared a cash dividend of $0.30 per share of outstanding common stock on Janua
XTANDI® (enzalutamide) Receives Health Canada Approval as the First and Only Treatment for High-Risk Patients with Non-Metastatic Castration-Sensitive Prostate Cancer (nmCSPC)
MARKHAM, ON, Jan. 30, 2024 /CNW/ – Today, Astellas Pharma Canada, Inc. announced that Health Canada has approved a supplemental New Drug Application for XTANDI® (enzalutamide) in a new prostate cancer treatment setting. With this approval, XTANDI becomes the first and only androgen receptor
DoorDash Will DoorDash Stuff From All the Big Game Ads to One Lucky Viewer
Win all the snacks, every vehicle, and, honestly, who knows what else from every commercial that airs during the broadcast in the most expansive Big Game giveaway ever Head to www.doordash-all-the-ads.com to learn more SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ — Today, DoorDash (NASDAQ: DASH),
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment
Pancreatic cancer has the highest mortality rate of all major cancers with only a 3% relative-survival-rate at 5-years for the advanced form. [1], [2] Pancreatic tumors are highly resistant to chemotherapy and radiation and there are limited treatment options[2] FDA ODD designation bolsters NeoImmu
Canon to demonstrate print technology leadership and inspire the Wide Format Graphics Community at FESPA Middle East 2024
DUBAI, UAE, Jan. 30, 2024 /PRNewswire/ — Canon Middle East is participating in FESPA Middle East from January 29 to 31, 2024, at the Dubai Exhibition Centre (Expo City). As the event’s Gold Sponsor, Canon will be showcasing its industry-leading printing solutions, while demonstrating its
FlexEnable launches flexible active optics evaluation kits for AR and VR
CAMBRIDGE, England, Jan. 30, 2024 /PRNewswire/ — FlexEnable, the leader in the development and production of flexible organic electronics for active optics and displays, today announces the launch of optical evaluation kits for AR and VR devices. The kits include ambient dimming and tunable le
Indian Lithium Iron Phosphate Batteries Market Report 2023-2024 and 2028
DUBLIN, Jan. 30, 2024 /PRNewswire/ — The “Lithium Iron Phosphate Batteries Market in India, 2024″ report has been added to ResearchAndMarkets.com’s offering. A comprehensive industry analysis signals expansion within India’s Lithium Iron Phosphate (LiFePO4) battery ma
Introducing EuroBar, the Bar Station where Functionality meets Design
MINNEAPOLIS, Jan. 30, 2024 /PRNewswire/ — EuroBar proudly introduces a new bar station with a level of sophistication, unmatched functionality, and ergonomic design that is setting a new benchmark in the industry. Inspired by the European bars’ elegance and effectiveness, EuroBar ushe
